FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays gives a Neutral rating
09/10/2021 | 02:20am EDT
Initially at the time of purchase, the broker revises his recommendation downwards. Hassan Al-Wakeel published a research note and has a neutral opinion. The target price is revised downwards from EUR 78 to EUR 74.